PTPRC and breast carcinoma: The same problem was shown by Bulfoni et al., who highlighted the lack of appropriate markers for the detection of all CTCs subpopulations [25], and found that apart from epithelial and epithelial-mesenchymal CTCs, subpopulation of CD45-negative cells in blood of breast cancer patients has clinical relevance.